MSB
Click for more information
6.00% 94.0¢ mesoblast limited

Cell Therapy News/Articles, page-14374

  1. reginaldp
    2,674 Posts.
    lightbulb Created with Sketch. 1722
    clock Created with Sketch.
    22/10/22
    08:53
    Post #: 64333645
    This part was interesting LED

    The Company has licensed the exclusive right to use, sell and distribute proprietary adult mesenchymal stem cells for all COVID-related and respiratory indications worldwide (some exclusions apply). Visit http://www.pulthera.com for more information about the Company.

    Reg
    MSB Price at posting: 96.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢ 		Change
-0.060(6.00%) 		Mkt cap ! $1.073B
Open High Low Value Volume
99.0¢ 99.5¢ 93.5¢ $5.643M 5.894M

Buyers (Bids)

No. Vol. Price($)
14 72266 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 20000 1
View Market Depth
Last trade - 16.10pm 02/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.